Sacral neuromodulation and sexual function: a systematic review and meta-analysis of the literature
Introduction and hypothesis
Sexual function is being increasingly recognized as an important patient-reported outcome. Sacral neuromodulation (SNM) is a treatment with an expanding list of indications. The effect of sacral neuromodulation on sexual function has been examined in a number of studies with variable results. In this review, we aim to systematically review the literature and pool the data if appropriate.
The literature search was conducted primarily on the Healthcare Databases Advanced Search (HDAS) platform using the Medline, EMBASE and CINHAL search engines. Of 196 initial citations, 17 articles met our predefined inclusion criteria. Thirteen studies reported enough information to be included in our meta-analysis. RevMan5 software was used for analysis.
Eight of 17 studies reported a positive effect of SNM on sexual function. Pooled analysis of data from 11 studies involving 573 patients before SNM and 438 patients after SNM showed significant improvement in sexual function (SMD = −0.39; 95% CI: −0.58 to −0.19; p = 0.0001). The results remained significant in most subgroup analyses except in patients suffering from fecal incontinence.
SNM in women with pelvic floor disorders, especially bladder dysfunction, seems to have a positive effect on sexual function. This needs to be verified in adequately powered primary research using sexual function as the primary outcome.
KeywordsSacral nerve stimulation Sacral neuromodulation Sex
We are grateful to the following authors who upon request supplied further information or anonymized data for the purpose of data synthesis: Mr. Anil Reddy , Dr. Rachel Pauls, Dr. Eunsun Yook , Dr. Mona Rydningen , Dr. Steven Siegel, Dr. Kellie Berg , Dr. Bradley Gill  and Dr. Gil-Sousa .
Compliance with ethical standards
Conflicts of interest
Aethele Khunda received an educational travel grant from Medtronic plc.
Carol McCormick: None to declare.
Paul Ballard: None to declare.
- 1.WHO. Defining sexual health: report of a technical consultation on sexual health 28–31 January 2002. Sexual health documents, vol chapter 3: working definitions. Geneva: World Health Organization; 2006.Google Scholar
- 4.Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208. https://doi.org/10.1080/009262300278597.CrossRefPubMedGoogle Scholar
- 6.Komesu YM, Rogers RG. Sexual function in women with pelvic floor and lower urinary tract disorder. Available from: http://www.uptodate.com/contents/sexual-function-in-women-with-pelvic-floor-and-lower-urinary-tract-disorders. Accessed 2nd of August 2018. 2016.
- 8.Imhoff LR, Brown JS, Creasman JM, Subak LL, Van den Eeden SK, Thom DH, et al. Fecal incontinence decreases sexual quality of life, but does not prevent sexual activity in women. Dis Colon Rectum. 2012;55(10):1059–65. https://doi.org/10.1097/DCR.0b013e318265795d.CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Bergeron CD, Goltz HH, Szucs L, Reyes JV, Wilson KL, Ory MG, et al. Exploring sexual behaviors and health communication among older women. Health Care Women Int. 2017. https://doi.org/10.1080/07399332.2017.1329308.
- 19.Ferhi K, Miaadi N, Tanneau Y, Leroi AM, Sibert L, Grise P. Results of sacral posterior neuromodulation on voiding disorders and impact on sexuality based on a single-center study. Progres en Urologie : Journal de l'Association Francaise d'urologie et de la Societe Francaise d'urologie. 2008;18(3):160–6. https://doi.org/10.1016/j.purol.2007.11.003.CrossRefGoogle Scholar
- 21.Ingber MS, Ibrahim IA, Killinger KA, Diokno AC, Peters KM. Neuromodulation and female sexual function: does treatment for refractory voiding symptoms have an added benefit? Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(9):1055–9. https://doi.org/10.1007/s00192-009-0900-3.CrossRefPubMedGoogle Scholar
- 23.Signorello D, Seitz CC, Berner L, Trenti E, Martini T, Galantini A, et al. Impact of sacral neuromodulation on female sexual function and his correlation with clinical outcome and quality of life indexes: a monocentric experience. J Sex Med. 2011;8(4):1147–55. https://doi.org/10.1111/j.1743-6109.2010.02189.x.CrossRefPubMedGoogle Scholar
- 26.Smart C, Jadav AM, Telford K. Sexual health for patients undergoing sacral nerve stimulation (SNS) for faecal incontinence. Color Dis. 2011;13(suppl 6):22.Google Scholar
- 27.Caremel R, Nouhaud FX, Leroi AM, Ruffion A, Michot F, Damon H, et al. Results of sacral neuromodulation on the urinary and fecal incontinence and sexuality in 20 women suffering from a double incontinence. Progres en Urologie: Journal de l'Association Francaise d'urologie et de la Societe Francaise d'urologie. 2012;22(7):424–32. https://doi.org/10.1016/j.purol.2012.01.015.CrossRefGoogle Scholar
- 28.van Voskuilen AC, Oerlemans DJ, Gielen N, Lansen-Koch SM, Weil EH, van Lankveld JJ, et al. Sexual response in patients treated with sacral neuromodulation for lower urinary tract symptoms or fecal incontinence. Urol Int. 2012;88(4):423–30. https://doi.org/10.1159/000336911.CrossRefPubMedGoogle Scholar
- 29.Altaf N, Maheswaran T, Reddy A. Can Sacral Neuro-modulation ofr faecal incontinence improve vaginal and sexual symptoms? Paper presented at the SAGES, Baltimore MD, 2013. https://www.sages.org/wp-content/uploads/posters/2013/45943.jpg. Accessed 2nd August 2018. 2011.
- 32.Banakhar M, Gazwani Y, Kelini ME, Al-Shaiji T, Hassouna M. Effect of sacral neuromodulation on female sexual function and quality of life: are they correlated? Can Urol Assoc J Journal de l'Association des Urologues du Canada. 2014;8(11-12):E762–7. https://doi.org/10.5489/cuaj.2300.CrossRefPubMedGoogle Scholar
- 33.Burke J, Capozzi P, Jadav AM, Smart C, Nicholson J, Sharma A, et al. Sexual health in patients undergoing sacral nerve stimulation for faecal incontinence. Color Dis. 2014;16(suppl 2):135.Google Scholar
- 34.Javidan AN, Mazel K, Latifi S, Maghari MM, Saberi H, Nikfalah A, et al. Outcomes of implementation of sacral nerve stimulation on urination, defecation, and sexual function in patients with spinal cord injury. Int J Color Dis. 2014;29(12):1577–8. https://doi.org/10.1007/s00384-014-1927-6.CrossRefGoogle Scholar
- 35.Gil-Sousa D, Castanheira de Oliveira M, Gomez M, Soares J, Fraga A. Assessment of sexual function in patients submitted to sacral neuromodulation. Paper presented at the ICS, Rio de Janeiro, 23/10/2014. 2014.Google Scholar
- 38.Siegel S, Noblett K, Mangel J, Griebling TL, Sutherland SE, Bird ET, et al. Three-year follow-up results of a prospective, multicenter study in overactive bladder subjects treated with sacral neuromodulation. Urology. 2016;94:57–63. https://doi.org/10.1016/j.urology.2016.04.024.CrossRefPubMedGoogle Scholar
- 39.Noblett K, Siegel S, Mangel J, Griebling TL, Sutherland SE, Bird ET, et al. Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder. Neurourol Urodyn. 2016;35(2):246–51. https://doi.org/10.1002/nau.22707.CrossRefPubMedGoogle Scholar
- 40.Rydningen M, Dehli T, Wilsgaard T, Rydning A, Kumle M, Lindsetmo RO, et al. Sacral neuromodulation compared with injection of bulking agents for faecal incontinence following obstetric anal sphincter injury—a randomized controlled trial. Col Dis Off J Assoc Coloproctology Great Britain Ireland. 2017;19(5):O134–44. https://doi.org/10.1111/codi.13632.CrossRefGoogle Scholar
- 41.Oliveira PS, Oliveira TR, Silva RP, Martinho D, Reis JP, Lopes TM. The impact of neuromodulation on sexual function. Int Urogynecol J. 2017;28(1):S257.Google Scholar
- 43.Chu CM, Arya LA, Andy UU. Impact of urinary incontinence on female sexual health in women during midlife. Women's Midlife Health 2015;1(6). https://doi.org/10.1186/s40695-015-0007-6.
- 44.Sand PK, Goldberg RP, Dmochowski RR, McIlwain M, Dahl NV. The impact of the overactive bladder syndrome on sexual function: a preliminary report from the multicenter assessment of transdermal therapy in overactive bladder with oxybutynin trial. Am J Obstet Gynecol. 2006;195(6):1730–5. https://doi.org/10.1016/j.ajog.2006.08.013.CrossRefPubMedGoogle Scholar